We are pleased to present below all posts archived in 'September, 2017'. If you still can't find what you are looking for, try using the search box.
SYDNEY, AUSTRALIA – (Sept 19, 2017). SpeeDx Pty, Ltd. has announced a distribution agreement with Diagen, a leading Scandinavian clinical laboratory supplier specialising in diagnostic products. This agreement will open important sales channels in Sweden, Norway and Denmark for SpeeDx’s PlexPCR® and unique, multiplexed ResistancePlus® real-time polymerase chain reaction product lines.
Read the rest of entry »
30 percent growth and innovation products wins Manchester company BVCA award
Having the right technology at the right time has made Elucigene Diagnostics a world leading developer and distributor of prenatal, rare disease and infertility genetics diagnostics. The Manchester-based company has been selected as the winner of the Venture-backed Management Team 2017 award for the Northwest in the prestigious British Private Equity & Venture Capital Association (BVCA) awards. Over the last two years it has seen 30 per cent year on year growth, and 85 percent of its revenue is coming from a growing international customer-base.
The new Streck Cell-Free DNA BCT® CE blood collection tubes, now available in the UK from Alpha Laboratories, contain a preservative that stabilises nucleated blood cells. This unique stabilisation prevents the release of genomic DNA (gDNA), allowing isolation of high-quality cell-free DNA (cfDNA) samples.
The new ProtectR® tubes, now available from Alpha Laboratories, have the only container closure system engineered to be CO2 resistant. This prevents costly damage to molecular and cellular solutions when shipping or storing samples on dry ice. Standard centrifuge tubes do not provide a reliable barrier against CO2 and even during short term dry ice storage can result in acidification of samples, with a decrease in pH by as much as 2.5 pH units. This acidification can affect the integrity and reproducibility of samples, and may result in a loss of protein activity.
Isohelix announces that their range of GenefiX DNA Saliva and Isohelix DNA Buccal Cell Collectors are both registered with the CFDA in the People’s Republic of China as certified IVD medical devices. The dual registration allows Isohelix and its partners, to substantially develop this territory with the knowledge of a 'full and wide market clearance', elevating Isohelix as a manufacturer of DNA and RNA Saliva Collection products in one of the largest international markets.
Who are the BIVDA Members
Member Press Releases
Point of Care Directory
News, Policy and Media
BIVDA Press Releases